Caxton Corp as of Dec. 31, 2022
Portfolio Holdings for Caxton Corp
Caxton Corp holds 17 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Savara (SVRA) | 27.3 | $11M | 6.9M | 1.55 | |
| Xeris Pharmaceuticals (XERS) | 20.5 | $8.0M | 6.0M | 1.33 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 15.6 | $6.1M | 16k | 382.43 | |
| Rezolute Com New (RZLT) | 7.4 | $2.9M | 1.4M | 2.07 | |
| Scynexis Com New (SCYX) | 6.9 | $2.7M | 1.7M | 1.56 | |
| Spdr Ser Tr S&p Oilgas Exp (XOP) | 6.1 | $2.4M | 18k | 135.88 | |
| Vectivbio Hldg Ord Shs | 3.4 | $1.3M | 156k | 8.62 | |
| Arcellx Common Stock (ACLX) | 2.9 | $1.1M | 36k | 30.98 | |
| Alps Etf Tr Alerian Mlp (AMLP) | 2.9 | $1.1M | 30k | 38.07 | |
| Compass Therapeutics (CMPX) | 2.7 | $1.1M | 211k | 5.03 | |
| Cabaletta Bio (CABA) | 2.0 | $784k | 85k | 9.25 | |
| Molecular Templates | 1.7 | $673k | 2.1M | 0.33 | |
| Allakos (ALLK) | 0.4 | $154k | 18k | 8.42 | |
| Elevation Oncology (ELEV) | 0.2 | $65k | 68k | 0.95 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $18k | 21k | 0.83 | |
| Bridgetown Holdings *w Exp 09/30/202 | 0.0 | $4.7k | 40k | 0.12 | |
| Lanvin Group Holdings Limite *w Exp 99/99/999 (LANV.WS) | 0.0 | $3.8k | 12k | 0.31 |
